Hauser Marta, Zhang Jian-Ping, Sheridan Eva M, Burdick Katherine E, Mogil Rachel, Kane John M, Auther Andrea, Carrión Ricardo E, Cornblatt Barbara A, Correll Christoph U
The Zucker Hillside Hospital, Psychiatry Research, North Shore-Long Island Jewish Health System, Glen Oaks, New York, USA.
Department of Psychiatry and Molecular Medicine, Hofstra North Shore-LIJ School of Medicine, Hempstead, New York, USA.
J Clin Psychiatry. 2017 Jan;78(1):e28-e40. doi: 10.4088/JCP.15r10197.
To compare neuropsychological performance in people at clinical high risk for psychosis (CHR), healthy controls (HCs), or subjects with first-episode psychosis (FEP).
Systematic PubMed/MEDLINE search through January 2014, without language restrictions, using search terms prodrome OR clinical high-risk OR ultra-high risk AND cognition OR individual test names.
Studies reporting neuropsychological data in CHR versus a HC or FEP groups or comparing CHR subjects who converted to psychosis (CHR-P) with CHR subjects who did not convert to psychosis (CHR-NP).
Two authors independently extracted and compared neurocognitive test data.
A meta-analysis was performed on 60 neuropsychological tests from 9 domains in 32 studies with 21 nonoverlapping samples (CHR = 1,684 patients, HC = 986, FEP = 405). Compared to HCs, people with CHR performed significantly worse in 7 of 9 domains (Hedges g effect size [95% confidence limit] = -0.17 [-0.30, -0.04] [attention/vigilance] to -0.42 [-0.64, -0.20] [verbal learning, speed of processing] and -0.43 [-0.68, -0.18] [social cognition]), except reasoning/problem solving and working memory (which separated in longitudinal studies). California Verbal Learning Test (-0.65 [-0.84, -0.46]) and Digit Symbol Test (-0.63 [-0.86, -0.40]) separated groups the most. Compared to FEP subjects, people with CHR performed significantly better in 5 of 6 domains (from 0.29 [0.03, 0.56] [speed of processing] to 0.39 [0.17, 0.62] [attention/vigilance, verbal learning] and -0.40 [0.18, 0.64] [working memory]), except reasoning/problem solving. CHR-P and CHR-NP performed significantly worse than HC (except visual learning, working memory in CHR-NP). Compared to CHR-NP, CHR-P performed significantly worse in 6 of 8 domains (from -0.24 [-0.44, -0.03] [attention/vigilance] to -0.49 [-0.76, -0.22] [verbal learning] and -0.54 [-0.80, -0.27] [visual learning]), without differences in reasoning/problem solving and working memory. Three individual tests (Rey-Osterrieth Complex Figure Test, Verbal Fluency Test/Controlled Oral Word Association Test, and California Verbal Learning Test) discriminated the best between CHR-P and CHR-NP (-0.49 [-0.82, -0.16], -0.45 [-0.86, -0.03], and -0.40 [-0.80, -0.00], respectively).
CHR has mild to moderate globally distributed neuropsychological performance deficits that lie between FEP and HCs. Neuropsychological performance deficits are greater in CHR-P than in CHR-NP, but they overlap, reducing their current utility for risk stratification.
比较精神病临床高危人群(CHR)、健康对照者(HCs)及首发精神病患者(FEP)的神经心理学表现。
截至2014年1月通过PubMed/MEDLINE进行系统检索,无语言限制,检索词为前驱症状或临床高危或超高危以及认知或个别测试名称。
报告CHR与HC或FEP组神经心理学数据,或比较转化为精神病的CHR受试者(CHR-P)与未转化为精神病的CHR受试者(CHR-NP)的研究。
两位作者独立提取并比较神经认知测试数据。
对32项研究中9个领域的60项神经心理学测试进行荟萃分析,涉及21个不重叠样本(CHR = 1684例患者,HC = 986例,FEP = 405例)。与HCs相比,CHR患者在9个领域中的7个领域表现明显更差(Hedges g效应量[95%置信区间]= -0.17[-0.30, -0.04][注意力/警觉性]至-0.42[-0.64, -0.20][言语学习、加工速度]和-0.43[-0.68, -0.18][社会认知]),推理/问题解决和工作记忆领域除外(在纵向研究中有所区分)。加利福尼亚言语学习测试(-0.65[-0.84, -0.46])和数字符号测试(-0.63[-0.86, -0.40])对组间的区分度最大。与FEP受试者相比,CHR患者在6个领域中的5个领域表现明显更好(从0.29[0.03, 0.56][加工速度]到0.39[0.17, 0.62][注意力/警觉性、言语学习]和-0.40[0.18, 0.64][工作记忆]),推理/问题解决领域除外。CHR-P和CHR-NP的表现均明显差于HC(CHR-NP的视觉学习、工作记忆领域除外)。与CHR-NP相比,CHR-P在8个领域中的6个领域表现明显更差(从-0.24[-0.44, -0.03][注意力/警觉性]到-0.49[-0.76, -0.22][言语学习]和-0.54[-0.80, -0.27][视觉学习]),推理/问题解决和工作记忆领域无差异。三项个别测试(雷-奥斯特里赫复杂图形测试、言语流畅性测试/受控口语单词联想测试和加利福尼亚言语学习测试)对CHR-P和CHR-NP的区分效果最佳(分别为-0.49[-0.82, -0.16]、-0.45[-0.86, -0.03]和-0.40[-0.80, -0.00])。
CHR存在轻度至中度的、全球分布的神经心理学表现缺陷,介于FEP和HCs之间。CHR-P的神经心理学表现缺陷比CHR-NP更严重,但二者存在重叠,降低了其目前在风险分层中的效用。